Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients

Table 5 Analysis of the threshold effects of triglyceride glucose-waist height ratio and triglyceride glucose-waist circumference levels on overall mortality

	One linear-regression model	Inflection point (K)	< K, effect 1	> K, effect 2	P value for LRT
TyG-WHtR	1.163 (1.099, 1.231); P < 0.0001	5.062	0.802 (0.626, 1.026); P = 0.0797	1.223 (1.146, 1.306); P < 0.0001	0.004
TyG-WC	1.101 (1.065, 1.138); P < 0.0001	870.1	0.891 (0.781, 1.017); P = 0.0880	1.137 (1.094, 1.182); P < 0.0001	0.002

The effects shown are adjusted for model 3, including sex, race, age, education, history of cardiovascular disease, previous hypertension and previous hyperlipidemia systolic blood pressure, diastolic blood pressure, duration of diabetes, proteinuria, heart failure, depression, smoking, glycated hemoglobin, total cholesterol, low-density lipoprotein cholesterol, estimated glomerular filtration rate, calcium channel blockers, beta-blockers, biguanides, thiazolidinediones, insulins, aspirin, statins and cholesterol absorption inhibitors. TyG: Triglyceride glucose; WHtR: Waist height ratio; WC: Waist circumference; LRT: Likelihood ratio test.